Alec Barclay Net Worth & Insider Trades
Alec Barclay - Chief Operations Officer, T2 Biosystems, Inc
What is Alec Barclay's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Chief Operations Officer, Alec Barclay, is estimated to be about $63.2K . Alec Barclay owns about 181,945 units of T2 Biosystems, Inc common stock. In the last 4 years at T2 Biosystems, Inc, Alec Barclay has sold an estimated value of $214.83K worth.
What is Alec Barclay's Past Insider Trading?
Alec Barclay's largest purchase order was 12,952 units , worth over $6.48K on April 11, 2022. Alec Barclay's largest sale order was 12,494 units , worth over $23.24K on March 18, 2021. In total, Alec Barclay has made about 17 transactions over 4 years of their time at T2 Biosystems, Inc. Alec Barclay usually trades in February, with the busiest year in 2018.
Alec Barclay
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Alec Barclay's Salary in 2020?
As Chief Operations Officer of T2 Biosystems, Inc, Alec Barclay has a total base salary of $340,000 . Alec Barclay received compensation valued at about $639,848 in 2020 after becoming Chief Operations Officer. The vast majority of their compensation came in the form of stock awards of $25,675 , option awards of $38,621 , other earnings, plans or compensations of $234,600 , and other compensation of $952 .
What is Alec Barclay's' Mailing Address?
- Mailing address is 101 Hartwell Ave. Lexington MA 02421 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on April 11, 2022 by John Sperzel III who bought 30,000 units worth $15K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, Director, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||